{"nct_id":"NCT02729025","title":"Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))","status":"COMPLETED","status_verified_date":"2022-09","start_date":"2016-04-14","start_date_type":"ACTUAL","primary_completion_date":"2018-04-05","primary_completion_date_type":"ACTUAL","completion_date":"2018-04-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}